Skip to content
Screener

Carlsmed, Inc. CARL Conversion Of Convertible Preferred Stock Upon Initial Public Offering

Conversion Of Convertible Preferred Stock Upon Initial Public Offering at other companies

Beta Bionics logo
Beta BionicsBBNX
$321.37M
Septerna, Inc. logo
Septerna, Inc.SEPN
$0-100%
Aardvark Therapeutics, Inc. logo
Aardvark Therapeutics, Inc.AARD
$0-100%
Beta Bionics logo
Beta BionicsBBNX
$57.35M
Hinge Health logo
Hinge HealthHNGE
$37.67M
CeriBell, Inc. logo
CeriBell, Inc.CBLL
$0-100%

Other financials

Income statement

See full
Revenue$18.9M+56.7%
Gross profit$14.5M+64.0%
Operating income-$11.0M-69.7%
Net income-$10.5M-55.3%
EPS (diluted)-$0.39+73.5%

Balance sheet

See full
Cash & equivalents$46.2M+38.2%
Total debt$21.9M+23.8%
Total equity$84.2M+201%
Total assets$118.2M+122%

Cash flow

See full
Operating cash flow-$7.4M-4.5%
CapEx$121.0K-63.0%
Free cash flow-$7.5M-1.5%

Valuation

See full
Market cap$374.05M+16.5%
Enterprise value$349.72M
P/S5.9×

Profitability

See full
Gross margin76.6%+2.6pp
Operating margin-61.1%-3.1pp
Net margin-57.4%-6.2pp
FCF margin-54.6%-10.6pp

Returns & leverage

See full
Return on equity-6,196.9%
Debt / equity0.3×
Current ratio8.8×+4.0×

Where this comes from

Reported directly by Carlsmed, Inc. in its filing.

Tagged under the XBRL concept carl:ConversionOfConvertiblePreferredStockUponInitialPublicOffering.

The source filing: Carlsmed, Inc.’s 10-K, filed February 25, 2026. Open the filing →

Filed
Feb 25, 2026, 4:09 PM EST
Fiscal year
FY2025
Accession
0001193125-26-071551

FAQ

What is Carlsmed, Inc.'s conversion of convertible preferred stock upon initial public offering?
Carlsmed, Inc. (CARL) reported conversion of convertible preferred stock upon initial public offering of $27.18M in Q4 2025.
What does conversion of convertible preferred stock upon initial public offering mean?
Captures the non-cash reclassification of preferred equity into common equity triggered by an initial public offering event. This transaction reflects the simplification of the company's capital structure as it transitions to a public entity. It is essential for understanding changes in shareholder dilution and equity composition.

Ask your AI about Carlsmed, Inc.'s conversion of convertible preferred stock upon initial public offering.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude